Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 13189-98-5
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
13189-98-5 |
Appearance:: |
Off-white Crystalline |
Molecular Formula:: |
C6H13NO3S |
Molecular Weight:: |
179.23700 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD00899873 |
CAS NO:: |
13189-98-5 |
Appearance:: |
Off-white Crystalline |
Molecular Formula:: |
C6H13NO3S |
Molecular Weight:: |
179.23700 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD00899873 |
Product Description:
Product Name: Fudosteine CAS NO: 13189-98-5
Synonyms:
Fudosteine (R)-2-Amino-3-(3-hydroxypropylthio)propionic acid;
(2R)-2-amino-3-(3-hydroxypropylsulfanyl)propanoic acid;
(r)-2-amino-3-(3-hydroxypropylthio)propionic acid;
Chemical & Physical Properties:
Appearance: Off-white crystalline
Assay :≥99.0%
Density: 1.301 g/cm3
Boiling Point: 354.5℃ at 760 mmHg
Melting Point: 210.9-212.5℃
Flash Point: 168.2℃
Refractive Index: 1.558
Vapor Pressure: 1.92E-06mmHg at 25℃
Storage Condition: -20℃ Freezer
Fudosteine is a novel mucoactive agent and a MUC5AC mucin hypersecretion inhibitor.Target: OthersFudosteine is a cysteine derivative that is used as an expectorant in chronic bronchial inflammatory disorders. The administration of fudosteine during the challenge with ovalbumin prevented the development of airway hyperresponsiveness and accumulation of lymphocytes in the airways. Eotaxin, IL-4, and TGF-β levels and the relative intensity of matrix metalloproteinase-2 and matrix metalloproteinase-9 (MMP-2 and MMP-9) in BAL fluid were reduced by the fudosteine treatment; however, the number of eosinophils in BAL fluid and serum IgE levels did not change. The expression of TGF-β, the development of goblet cell hyperplasia, subepithelial collagenization, and basement membrane thickening were also reduced by the fudosteine treatment. Fudosteine inhibits MUC5AC mucin hypersecretion by reducing MUC5AC gene expression and the effects of fudosteine are associated with the inhibition of extracellular signal-related kinase and p38 mitogen-activated protein kinase in vivo and extracellular signal-related kinase in vitro.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.